UnitedHealth said on Friday that audits by outside consulting firms of its health services and pharmacy benefit units would ...

Based on the results, UnitedHealth Group has outlined multiple steps it plans to take to improve operations. The company's ...

UnitedHealth Group is undergoing operational changes to enhance automation and standardization following audits of its health ...

The health-care giant drops internal reviews amid DOJ probes, earnings pressure, and a brutal 35% stock decline in 2025.

UnitedHealth Group (NYSE: UNH) has endured a brutal 2025, with shares down approximately 35% year-to-date. This marks the ...

UnitedHealth (UNH) stock is in focus as the company gets results of its first outside reviews. Read more here.

UnitedHealth Group ($UNH) announced the preliminary results from extensive independent audits of its business practices and ...

UnitedHealth Group Incorporated is rated a Buy with profits recovering and the foundation set for renewed growth. Learn more ...

In a latest development, UnitedHealth Group Incorporated (NYSE:UNH) has agreed to sell Banmedica, its last remaining business ...

UnitedHealth Group is far from the perfect stock, but it is an appealing buy because it can learn from its errors and ...

UnitedHealth is selling Banmedica, its final South American unit, to Patria Investments for $1 billion as it completes its exit from the region. The divestiture supports CEO Stephen Hemsley’s ...

UnitedHealth Group has reached a deal to sell its Latin American business Banmedica for $1 billion, according to media reports. Sources told Reuters that the healthcare giant will sell the unit to a ...